Jefferies Financial Group Inc. Novavax Inc Put Options Transaction History

Jefferies Financial Group Inc.

  • $8.87 Billion
  • Q2 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$3.89 - $20.97 $25,674 - $138,402
6,600 Added 10.11%
71,900 $910,000
Q1 2024

May 13, 2024
BUY
$3.76 - $6.02 $33,840 - $54,179
9,000 Added 15.99%
65,300 $312,000
Q4 2023

Feb 13, 2024
BUY
$4.8 - $7.67 $270,240 - $431,821
56,300 New
56,300 $270,000
Q4 2022

Sep 21, 2023
BUY
$8.86 - $25.04 $198,464 - $560,896
22,400 New
22,400 $230,000
Q4 2022

Feb 14, 2023
BUY
$8.86 - $25.04 $198,464 - $560,896
22,400 New
22,400 $230,000

Others Institutions Holding NVAX

# of Institutions
284
Shares Held
83.2M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $988M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email